In all four patients, CSF VEGF levels were substantially reduced upon therapy and these patients experienced a partial (n=2) or complete (n=2) resolution of clinical symptoms; three patients were also evaluable for a cytological response: one patient with oligodendroglioma showed CSF clearance of malignant cells, in two patients CSF was not cleared. This evidence concerns the gene VEGFA and oligodendroglioma.